Hepatitis E vaccine [2]

New England Journal of Medicine

Volumn 356, Issue 23, 2007, Pages 2421-2422

  Bhattarai, Achuyt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; TYPHOID VACCINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ETHICS; HEPATITIS E; HIGH RISK POPULATION; HUMAN; LETTER; MEDICAL RESEARCH; NEPAL; PRIORITY JOURNAL; SOLDIER;

EID: 34250029032     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070884     Document Type: Letter

References (4)

1. Stevenson P. Nepal calls the shots in hepatitis E virus vaccine trial. Lancet 2000;355:1623.
2. Andrews J. Research in the ranks: vulnerable subjects, coercible collaboration, and the hepatitis E vaccine trial in Nepal. Perspect Biol Med 2006;49:35-51.
3. Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: a preliminary report. N Engl J Med 1987;317:1101-4.
4. World Medical Association. Decleration of Helsinki: ethical principles for medical research involving human subjects: basic principles for all medical research. Article 19. 2007. (Accessed May 17, 2007, at http://www.wma.net/e/ policy/b3.htm.)